Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

NCT05883306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics of 14C-labeled of LXI-15028

Interventions

DRUG: [14C]LXI-15028

Sponsor

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.